CureVac AG, a clinical stage biopharmaceutical company pioneering the field of mRNA-based drugs, announced that Jean Stéphenne, former deputy Chairman of the Supervisory Board, has been appointed as the new Chairman with immediate effect.
April 2, 2020
· 2 min read